MedPath

Exercise Adherence and Cognitive Decline: Phase 2

Not Applicable
Not yet recruiting
Conditions
Cognitive Decline
Registration Number
NCT07127965
Lead Sponsor
University of Colorado, Boulder
Brief Summary

The purpose of this study is to conduct a test of a goals-based program to help people exercise more. This program was designed for individuals aged 45-65 from the Black community. Low levels of physical activity are related to health problems such as heart disease, diabetes, and cognitive decline. People of color are more negatively impacted by these conditions and have also historically been underrepresented by research seeking to increase physical activity. The investigators have developed this goals-based exercise promotion program with the help of a Black-led community-based organization (The Gyedi Project) and a Community Advisory Board made up of stakeholders in the Black community.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
226
Inclusion Criteria
  • <3 incorrect responses on the Pfeiffer Mental Status Questionnaire
  • Ages 45 to 65
  • Consent to be randomized to conditions
  • Planning to remain in the Denver metro area for the next 14 months
  • Identify as Black or African American
Exclusion Criteria
  • Currently physically active (i.e., >90 min/week of moderate PA or >40 min/week of vigorous PA consistently for the past 6 months)
  • On antipsychotic medications or currently under treatment for any serious psychiatric disorder including Alzheimer's or dementia
  • Inability to walk 3 blocks without chest pain, shortness of breath, or lightheadedness
  • Inability to climb 2 flights of stairs without chest pain, shortness of breath, or lightheadedness

PCP Exclusion Criteria:

  • Answers "yes" to 1 or more of the 7 general questions of the PAR-Q+ and answers yes to any of the follow up questions.
  • Blood pressure at baseline is greater than 160/100
  • Blood pressure at baseline is between 140/90 - 160/100 and the participant is currently taking blood pressure medication
  • Blood pressure > 210/90 mmHg (for men) or > 190/90 mmHg (for women) immediately after exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Blood PressureBaseline, Visit 15 (6 Months after baseline), Visit 17 (12 months after baseline)

Blood pressure (systolic and diastolic) of all participants is collected before the intervention

Activity LevelsBaseline, Visit 15 (6 months after baseline), Visit 17 (12 months after baseline)

Exercise Intensity (PAR). Answers are direct (ex. how many hours active) and not scaled. Information is requested for the week and the past 3 months.

Sleep LevelsBaseline, Visit 15 (6 months after baseline), Visit 17 (12 months after followup)

Exercise Intensity (PAR). Answers are direct (ex. how many hours did you sleep) and are not scaled. Information is requested for the past 7 days.

Exercise IntensityBaseline, Visit 15 (6 months after baseline), Visit 17 (12 months after baseline)

Exercise Intensity (PAR). Answers are direct (ex. how many hours did you sleep) and are not scaled. Information is requested for the past 7 days.

Ventilatory ThresholdBaseline

Talk Test. Graded treadmill test where intensity is increased at intervals to determine participant's ventilatory threshold.

Pain LevelsVisits 2, 6, 12 (Supervised Exercise Training)

A single item measure from Borg (1998) was used to assess participants' pain levels during the exercise bout. Participants were asked to indicate how much pain they felt \[at that moment/during the past ten minutes\] on an 11-point scale ranging from 0 (nothing at all) to 10 (excruciating).

Affective ArousalVisits 2, 6, 12 (Supervised Exercise Training)

The Felt Arousal Scale, a single-item measure from Svebak and Murgatroyd (1985), was used to assess participants' affective arousal during the exercise bout. Participants were asked to indicate how "worked-up" they felt \[at that moment/during the past ten minutes\] on a 6-point scale ranging from 1 (low arousal) to 6 (high arousal).

EnjoymentVisits 2, 6, 12 (Supervised Exercise Training)

A single item measure from Gillman and Bryan (2015) was used to assess participants' enjoyment levels during the exercise bout. Participants were asked to indicate how enjoyable exercise was \[at that moment/during the past ten minutes\] on a 5-point scale ranging from 1 (no enjoyment at all) to 5 (a great deal of enjoyment).

DemographicsBaseline

Survey includes gender, sexual orientation, age, detailed race/ethnicity, and SES

Objective Physical ActivityBaseline, Visit 15 (6 months after baseline), Visit 17 (12 months after baseline)

Objective physical activity will be measured through ActiGraph. Participants will be given the ActiGraph at baseline and will be asked to wear the device for one week. Participants will then be asked to wear the watch continuously for the week before visit 15 (6-month follow-up) and visit 17 (12-month follow-up).

Exercise BehaviorAll study timepoints (Visits 1-17; approximately 14 months)

modified Godin Shepard Leisure Time Physical Activity Questionnaire. Measures physical and leisure activity over a typical one week period

Theoretical Mediators of Exercise BehaviorBaseline, Visit 12 (supervised exercise visit), Visits 14-17 (3, 6, 9, and 12 months after baseline)

Exercise alignment with Black identity. Assessment of the extent to which 7 common exercises are aligned with Black identity

Heart RateBaseline, Visits 2-13 (Supervised Exercise Training, 1 hour 3x/week for 4 weeks), Visit 15 (6-month follow-up), Visit 17 (12-month follow-up)

Heart Rate is measured using chest strap monitor.

Perceived ExertionBaseline, Visits 2-13 (Supervised Exercise Training, 1 hour 3x/week for 4 weeks)

A single-item measure from Borg (1973) was used to assess participants' rate of perceived exertion (RPE) during the exercise bout. Participants were asked to rate the average intensity of exercise \[at that moment/during the past ten minutes\] on a 25-point scale ranging from 6 (no exertion at all) to 20 (maximal exertion).

DietBaseline, Visit 17 (12-month follow-up)

NCI's Eating at America's Table Study (EATS) Fruit \& Vegetable All-Day Screener. A short dietary assessment instrument for measuring fruit and vegetable intake over the past month.

Biomarkers of Cognitive AgingBaseline and Visit 17 (12 months after baseline)

Biomarkers of cognitive again will be analyzed by blood samples. Blood samples will be collected at baseline and Visit 17 (12-month follow-up) and stored. At the end of the study, samples will be sent for analysis of biomarkers involved in cognitive aging, including p-tau181, NfL, Ab40, Ab42, GFAP, and IGF-1.

Heart Rate VariabilityBaseline, Visit 17 (12 months after Baseline)

Heart Rate Variability is measured using chest strap monitor.

Affective ValenceVisit 12, Visits 14-16 (3, 6, and 9 months after baseline)

The Feeling Scale, a single-item measure from Hardy and Rejeski (1989), was used to assess participants' affective valence during the exercise bout. Participants were asked to indicate how they felt \[at that moment/during the past ten minutes\] on an 11-point scale ranging from -5 (very bad) to +5 (very good).

Exercise Check-InVisits 14-17 (3, 6, 9, and 12 months after baseline)

Three short questions assessing if the participant planned to engage in exercise and how many minutes of moderate (0-120) and vigorous (0-60) exercise they engaged in

Exercise Benefits and BarriersBaseline, Visit 12 (supervised exercise visit), Visits 14-17 (3, 6, 9, and 12 months after baseline)

A 10 item scale assessing perceived benefits of and barriers to exercise

AnthropometricsBaseline, Visit 17 (12-month follow-up)

Weight will be measured in pounds

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Recreation Centers in the Denver Metro Area

🇺🇸

Aurora, Colorado, United States

University of Colorado at Boulder

🇺🇸

Boulder, Colorado, United States

Recreation Centers in the Denver Metro Area
🇺🇸Aurora, Colorado, United States
Sarah Frances Crawford, B.A
Contact
423-771-1244
Sarah.Crawford-1@colorado.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.